Stobadine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStobadine
Drug Alias NameDH-1011 (diHCl)DP-1031 (dipalmitate)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsDiabetes ComplicationsArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A